Document is current
Any future updates will be listed below
-
Authors
Moyo, Sabrina John https://orcid.org/0000-0003-4735-1513
Justine, Museveni
Blomberg, Bjørn
Löhr, Iren Høyland
Gideon, Joshua
Mdoe, Paschal
Mduma, Estomih
Manyahi, Joel
Pettersen, Veronika Kuchařová
Paschal, John
Syre, Heidi
Bukhay, Rehema
Klingenberg, Claus
Langeland, Nina
-
Funding
Funding for this research was provided by:
Helse Vest Regionalt Helseføretak (912267)
Trond Mohn stiftelse (TMS2020TMT11)
JPIAMR (NFR333432)
Helse Nord RHF (HNF-1512–20)
Helse Nord RHF (HNF1705–24)
University of Bergen
- License Information
-
More Information
Article History
Received: 5 July 2025
Accepted: 7 January 2026
First Online: 15 January 2026
Declarations
:
: This study was conducted in accordance with the latest South Africa revision of the Declaration of Helsinki, good clinical practice, and local and international regulatory requirements. Ethical approval of the ProRIDE Trial was obtained from the Regional Committee for Medical and Health Research Ethics Western Norway in September 2019 (REK Vest 2019/1025), from the National Institute of Medical Research in Tanzania (NIMR) in April 2020 and from Tanzania Medicines and Medical Devices Authority (TMDA). Written informed consent was obtained from Parent/caretaker.
: Not applicable.
: The authors declare that they have no competing interests.
